Nathan R Every's Net Worth
$340 Million
Who is Nathan R Every?
Nathan R Every has an estimated net worth of $340 Million. This is based on reported shares across multiple companies, which include GLAUKOS Corp, COLLEGIUM PHARMACEUTICAL, INC, ANAPTYSBIO INC, and Sierra Oncology, Inc..
SEC CIK
Nathan R Every's CIK is 0001531105
Past Insider Trading and Trends
2017 was Nathan R Every's most active year for acquiring shares with 16 total transactions. Nathan R Every's most active month to acquire stocks was the month of December. 2017 was Nathan R Every's most active year for disposing of shares, totalling 12 transactions. Nathan R Every's most active month to dispose stocks was the month of December. 2017 saw Nathan R Every paying a total of $13,066,838.50 for 7,376,894 shares, this is the most they've acquired in one year. In 2015 Nathan R Every cashed out on 14,562,312 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
GLAUKOS Corp (GKOS) Snapshot price: $94.47
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.6M |
—
|
—
| 2.6M |
Jun 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
COLLEGIUM PHARMACEUTICAL, INC (COLL) Snapshot price: $33.2
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.89M |
$12.00 |
—
| 1.89M |
May 12
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
ANAPTYSBIO INC (ANAB) Snapshot price: $23.518
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -58.49% | -1.37M |
—
|
—
| 973.61K |
May 11
| |||
Form 4
| -58.49% | -1.37M |
—
|
—
| 973.61K |
May 11
| |||
Form 4
| +5.26% | 117.23K |
$4.55 | $533,419.25 | 2.35M |
Feb 2
| |||
Form 4
| +5.26% | 117.23K |
$4.55 | $533,419.25 | 2.35M |
Feb 2
| |||
Form 4
|
∞
| 3.57M |
$15.00 | $6,000,000.00 | 3.57M |
Jan 31
| |||
Form 4
|
∞
| 3.57M |
$15.00 | $6,000,000.00 | 3.57M |
Jan 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Sierra Oncology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |